Center of Neonatal Disease Screening, Department of Clinical Genetics, Northwest Women's and Children's Hospital, China.
Berry Genomics Corporation, Beijing 102200, China.
Clin Chim Acta. 2024 Mar 1;555:117820. doi: 10.1016/j.cca.2024.117820. Epub 2024 Feb 1.
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders predominantly characterized by impaired corticosteroid synthesis. Clinical phenotypes include hypoadrenocorticism, electrolyte disturbances, abnormal gonadal development, and short stature, of which severe hyponadrenocorticism and salt wasting can be life-threatening. Genetic analysis can help in the clinical diagnosis of CAH. However, the 21-OHD-causing gene CYP21A2 is arranged in tandem with the highly homologous CYP21A1P pseudogene, making it difficult to determine the exact genotypes using the traditional method of multiplex ligation-dependent probe amplification (MLPA) plus Sanger sequencing or next-generation sequencing (NGS). We applied a long-read sequencing-based approach termed comprehensive analysis of CAH (CACAH) to 48 newborns with CAH that were diagnosed by clinical features and the traditional MLPA plus Sanger sequencing method for retrospective analysis, to evaluate its efficacy in the clinical diagnosis of neonatal CAH. Compared with the MLPA plus Sanger sequencing method, CACAH showed 100 % consistency in detecting SNV/indel variants located in exons and exon-intron boundary regions of CAH-related genes. It can directly determine the cis-trans relationship without the need to analyze parental genotypes, which reduces the time to diagnosis. Moreover, CACAH was able to distinguish different CYP21A1P/CYP21A2 and TNXA/TNXB chimeras, and detect additional variants (CYP21A2 variants c.-121C > T, c.*13G > A, c.*52C > T, c.*440C > T, c.*443 T > C, and TNXB variants c.12463 + 2 T > C, c.12204 + 5G > A). We also identified the TNXB variant c.11435_11524 + 30del alone instead of as a part of the TNXA/TNXB-CH-1 chimera in two newborns, which might be introduced by gene conversion. All of these characteristics enabled clinicians to better explain the phenotype of subjects and manage them more effectively. CACAH has a great advantage over the traditional MLPA and Sanger sequencing methods, showing substantial potential in the genetic diagnosis and screening of neonatal CAH.
先天性肾上腺皮质增生症 (CAH) 是一组常染色体隐性遗传病,主要表现为皮质醇合成障碍。临床表现包括肾上腺皮质功能减退、电解质紊乱、性腺发育异常和身材矮小,其中严重的肾上腺皮质功能减退和盐耗竭可能危及生命。基因分析有助于 CAH 的临床诊断。然而,21-羟化酶缺陷基因 CYP21A2 与高度同源的 CYP21A1P 假基因串联排列,使得使用传统的多重连接依赖性探针扩增 (MLPA) 加 Sanger 测序或下一代测序 (NGS) 方法确定确切的基因型变得困难。我们应用一种基于长读测序的方法,称为 CAH 综合分析 (CACAH),对 48 例通过临床特征和传统 MLPA 加 Sanger 测序方法诊断的 CAH 新生儿进行回顾性分析,以评估其在新生儿 CAH 临床诊断中的应用效果。与 MLPA 加 Sanger 测序方法相比,CACAH 在检测位于 CAH 相关基因外显子和外显子-内含子边界区域的 SNV/indel 变异方面具有 100%的一致性。它可以直接确定顺式-反式关系,而无需分析父母的基因型,从而缩短了诊断时间。此外,CACAH 能够区分不同的 CYP21A1P/CYP21A2 和 TNXA/TNXB 嵌合体,并检测到额外的变异 (CYP21A2 变异 c.-121C>T、c.*13G>A、c.*52C>T、c.*440C>T、c.*443T>C 和 TNXB 变异 c.12463+2T>C、c.12204+5G>A)。我们还在两名新生儿中发现了 TNXB 变异 c.11435_11524+30del 单独存在,而不是作为 TNXA/TNXB-CH-1 嵌合体的一部分,这可能是由基因转换引起的。所有这些特征使临床医生能够更好地解释受试者的表型,并更有效地对其进行管理。CACAH 比传统的 MLPA 和 Sanger 测序方法具有很大的优势,在新生儿 CAH 的遗传诊断和筛查方面具有巨大的潜力。